Emergent Biosolutions El-Hibri

Fuad El-Hibri has filed an intention with the SEC to sell 1.1 million shares of stock:
On January 20, 2009, Emergent Biosolutions announces that Fuad El-Hibri has filed an intention with the SEC to sell 1.1 million shares of stock: 13.5 million shares had been issued to date with 47% controlled by Fuad El-Hibri. It also announced Stage II testing of vaccines for Typhoid, Hepatitis B, and Tuberculosis.

Related posts:

  1. Emergent BioSolutions Inc. (EBS) CEO & Chairman, 10% Owner Fuad El-hibri sells 15,000 Shares CEO & Chairman, 10% Owner of Emergent BioSolutions Inc. (EBS)...
  2. Emergent BioSolutions Inc., Q2 2009 Earnings Call Transcript Emergent BioSolutions Inc., (EBS) Q2 2009 Earnings Call August 6,...
  3. Fuad El-Hibri on AOL Money For commercial markets, Emergent is working on therapies and...

Related posts brought to you by Yet Another Related Posts Plugin.

Submitted by admin on Fri, 08/14/2009 - 05:23.